The Commerce Department's CHIPS Research and Development Office quietly signed letters of intent with seven companies to provide a combined $874 million in federal funding, with the National Institute of Standards and Technology confirming the government will take minority, non-voting equity stakes in each firm as a condition of the awards. The seven companies are GlobalFoundries, Kepler, Multibeam Corporation, Extropic, Thintronics, OBSIDIA Semiconductors, and Aeluma, spanning technologies from advanced integrated photonics to next-generation compute architectures and memory for AI systems.From Grants to Ownership StakesThe arrangement marks a continuation of a policy shift that began with the CHIPS and Science Act's implementation, in which the federal government has moved away from simply issuing grants toward demanding an ownership position in exchange for taxpayer funding. Commerce Secretary Howard Lutnick's department has now made this equity-for-funding model a recurring feature of how it disburses CHIPS Act dollars, rather than a one-off arrangement limited to the earliest, highest-profile deals with companies like Intel.What the Money Is ForAccording to NIST's disclosure, the funding will support research and development on critical technologies including advanced integrated photonics, a microchip approach that uses light rather than electricity to move and process data, promising significant efficiency gains for data-intensive AI workloads, along with research into compute architectures and memory systems tailored for artificial intelligence. Both are areas widely seen as the next frontier for chip performance gains as traditional transistor scaling slows.The Political Fight Over “State Capitalism”The move has drawn sharp criticism from commentators who argue it represents an inappropriate expansion of government's role in private enterprise. A Washington Post opinion piece published August 3 accused Lutnick of “hoovering up equity stakes” and labeled the approach a form of state capitalism incompatible with traditional American free-market norms. Critics on both the left and right have raised concerns, with some arguing it distorts competitive markets by giving the government a financial stake in which companies succeed, while others worry it sets a precedent for politically motivated allocation of research funding.The Administration's DefenseSupporters of the approach argue that if taxpayers are footing hundreds of millions of dollars in R&D funding, the public should share in any resulting upside rather than simply subsidizing private companies' balance sheets with no return. Proponents also frame the equity stakes as a hedge against strategic risk, ensuring that critical technologies like advanced photonics and AI-specific memory architectures remain domestically anchored rather than dependent on funding structures that could shift ownership toward foreign investors.Not a Done Deal YetCrucially, the announced figures represent maximum potential funding levels, not finalized grants. Each of the seven deals still requires additional government review and formal approval before any money changes hands or equity stakes are formally recorded, meaning the details, and possibly the dollar amounts, could still shift before implementation. That leaves room for both congressional scrutiny and potential renegotiation as the individual agreements move through final approval.What It Means NextThe pattern signals that equity-for-funding has become the default template for CHIPS Act disbursements going forward, not an exception reserved for marquee deals with the largest chipmakers. For the seven companies involved, most of them smaller, more specialized firms than the sector's biggest names, the arrangement offers crucial capital for capital-intensive R&D, but at the cost of giving Washington a permanent, if non-voting, seat at the table. Expect continued political debate over the model as more such deals are finalized in the months ahead, particularly if any of these companies eventually go public or get acquired, moments that would test how the government's equity stake actually gets valued and cashed out.The current round of equity-for-funding deals follows a pattern set by earlier, larger CHIPS Act awards to companies such as Intel, where the federal government similarly converted a portion of grant funding into equity, a move that drew significant controversy at the time but has since become normalized as the department's standard operating approach. Unlike those earlier marquee deals involving established manufacturing giants, this latest batch targets smaller, more specialized firms working on emerging technologies, meaning the government's exposure is spread across higher-risk, earlier-stage ventures rather than concentrated in a single, already-profitable company.Some industry analysts argue that spreading equity stakes across smaller, more experimental firms actually represents a more traditional venture-style approach to public R&D investment, even if it invites the same political criticism leveled at the Intel deal, since taxpayers now have direct financial exposure to whether cutting-edge but commercially unproven technologies like photonic computing ultimately succeed.